Hospital das Clinicas da UFPR

Curitiba, Paraná 80060-150

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Non Small Cell Lung Carcinoma, Pneumonia

Studies at this site

• Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed